StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences total assets

Total assets on the balance sheet at the end of each period.

Arcadia Biosciences's total assets was $5.89M at Jun 30, 2026. For fiscal 2025 it was $6.55M, down 51.6% from the year before. Over ten years it grew -21.6% a year on average. The highest annual figure on record is $74.24M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.55M-51.6%
FY2024Dec 31, 2024$13.52M-31.4%
FY2023Dec 31, 2023$19.71M-31.9%
FY2022Dec 31, 2022$28.92M-34.1%
FY2021Dec 31, 2021$43.92M-7.2%
FY2020Dec 31, 2020$47.35M+45.4%
FY2019Dec 31, 2019$32.57M+35.6%
FY2018Dec 31, 2018$24.02M+45.0%
FY2017Dec 31, 2017$16.57M-70.7%
FY2016Dec 31, 2016$56.57M-23.8%
FY2015Dec 31, 2015$74.24M+198.3%
FY2014Dec 31, 2014$24.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.89M-24.3%
Q1 FY2026Mar 31, 2026$5.32M-59.0%
Q4 FY2025Dec 31, 2025$6.55M-51.6%
Q3 FY2025Sep 30, 2025$8.58M-43.7%
Q2 FY2025Jun 30, 2025$7.79M-55.2%
Q1 FY2025Mar 31, 2025$12.99M-19.0%
Q4 FY2024Dec 31, 2024$13.52M-31.4%
Q3 FY2024Sep 30, 2024$15.24M-35.1%
Q2 FY2024Jun 30, 2024$17.37M-35.2%
Q1 FY2024Mar 31, 2024$16.05M-47.2%
Q4 FY2023Dec 31, 2023$19.71M-31.9%
Q3 FY2023Sep 30, 2023$23.47M-31.9%
Q2 FY2023Jun 30, 2023$26.80M-23.5%
Q1 FY2023Mar 31, 2023$30.41M-21.6%
Q4 FY2022Dec 31, 2022$28.92M-34.1%
Q3 FY2022Sep 30, 2022$34.47M-41.8%
Q2 FY2022Jun 30, 2022$35.01M-50.6%
Q1 FY2022Mar 31, 2022$38.80M-45.2%
Q4 FY2021Dec 31, 2021$43.92M-7.2%
Q3 FY2021Sep 30, 2021$59.23M+74.8%
Q2 FY2021Jun 30, 2021$70.80M+87.4%
Q1 FY2021Mar 31, 2021$70.80M+119.5%
Q4 FY2020Dec 31, 2020$47.35M+45.4%
Q3 FY2020Sep 30, 2020$33.88M-9.2%
Q2 FY2020Jun 30, 2020$37.78M+49.0%
Q1 FY2020Mar 31, 2020$32.25M+46.9%
Q4 FY2019Dec 31, 2019$32.57M+35.6%
Q3 FY2019Sep 30, 2019$37.30M+37.1%
Q2 FY2019Jun 30, 2019$25.35M-18.6%
Q1 FY2019Mar 31, 2019$21.95M-2.9%
Q4 FY2018Dec 31, 2018$24.02M+45.0%
Q3 FY2018Sep 30, 2018$27.22M+43.4%
Q2 FY2018Jun 30, 2018$31.13M-35.7%
Q1 FY2018Mar 31, 2018$22.60M-57.1%
Q4 FY2017Dec 31, 2017$16.57M-70.7%
Q3 FY2017Sep 30, 2017$18.98M-69.2%
Q2 FY2017Jun 30, 2017$48.43M–
Q1 FY2017Mar 31, 2017$52.65M–
Q4 FY2016Dec 31, 2016$56.57M–
Q3 FY2016Sep 30, 2016$61.59M–

More Arcadia Biosciences figures

See a number that looks wrong?